Methylation at CPT1A locus is associated with lipoprotein subfraction profi les

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1324-1330

  Frazier Wood, Alexis C ^a   Aslibekyan, Stella ^b   Absher, Devin M ^b,c   Hopkins, Paul N ^d   Sha, Jin ^b   Tsai, Michael Y ^e   Tiwari, Hemant K ^b   Waite, Lindsay L ^b,c   Zhi, Degui ^b   Arnett, Donna K ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Carnitine palmitoyltransferase 1A; Epigenome wide association study; Genetics of Lipid Lowering Drugs and Diet Network; High density lipoprotein size; Lipoprotein diameter; Lipoprotein particle number; Low density lipoprotein size; Nuclear magnetic resonance data; Very low density lipoprotein size

Indexed keywords

ANTILIPEMIC AGENT; CARNITINE PALMITOYLTRANSFERASE I; CPG OLIGODEOXYNUCLEOTIDE; DNA; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A, HUMAN;

ADULT; ARTICLE; CARDIOMETABOLIC RISK; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CPG ISLAND; CPT1A GENE; DNA METHYLATION; EPIGENETICS; FEMALE; FRACTIONATION; GENE; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; GENETICS; METABOLISM; MULTICENTER STUDY;

CARNITINE O-PALMITOYLTRANSFERASE; CPG ISLANDS; DNA METHYLATION; FEMALE; GENETIC LOCI; HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE;

EID: 84903954905     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M048504     Document Type: Article

References (35)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). 2001. JAMA. 285: 2486-97. [online] http://www.ncbi.nlm.nih.gov/pubmed/11368702 (Accessed May 22, 2013).
2. Voight, B. F., G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Hólm, E. L. Ding, T. Johnson, et al. 2012. Plasma HDL cholesterol and risk of myocardial2013). infarction: a mendelian randomisation study. Lancet. 380: 572-80. [online] http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=3419820&tool= pmcentrez&rendertype=abstract (Accessed May 21, 2013).
3. Campos, H., L. A. Moye, S. P. Glasser, M. J. Stampfer, and F. M. Sacks. 2001. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA. 286: 1468-1474. [online] PM:11572739.
4. Gray, R. S., D. C. Robbins, W. Wang, J. L. Yeh, R. R. Fabsitz, L. D. Cowan, T. K. Welty, E. T. Lee, R. M. Krauss, and B. V Howard. 1997. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 17: 2713-2720. [online] PM:9409247.
5. Festa, A., K. Williams, A. J. Hanley, J. D. Otvos, D. C. Goff, L. E. Wagenknecht, and S. M. Haffner. 2005. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation. 111: 3465-3472.
6. Frazier-Wood, A. C., S. Glasser, W. T. Garvey, E. K. Kabagambe, I. B. Borecki, H. K. Tiwari, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, and D. K. Arnett. 2011. A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids Health Dis. 10: 237. [online] http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3260106& tool=pmcentrez&rendertype=abstract (Accessed February 6, 2012).
7. Garvey, W. T., S. Kwon, D. Zheng, S. Shaughnessy, P. Wallace, A. Hutto, K. Pugh, A. J. Jenkins, R. L. Klein, and Y. Liao. 2003. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 52: 453-462.
8. Goff, D. C., Jr., R. B. D'Agostino, Jr., S. M. Haffner, and J. D. Otvos. 2005. Insulin resistance and adiposity infl uence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 54: 264-270.
9. Syvanne, M., M. Ahola, S. Lahdenpera, J. Kahri, T. Kuusi, K. S. Virtanen, and M. R. Taskinen. 1995. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res. 36: 573-582. [online] PM:7775869.
10. Chasman, D. I., G. Paŕ, S. Mora, J. C. Hopewell, G. Peloso, R. Clarke, L. A. Cupples, A. Hamsten, S. Kathiresan, A. Mälarstig, et al. 2009. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 5: e1000730. [online] http://dx. plos.org/10. 1371/journal. pgen. 1000730 (Accessed September 28, 2011).
11. Frazier-Wood, A. C., A. Manichaikul, S. Aslibekyan, I. B. Borecki, D. C. Goff, P. N. Hopkins, C-Q. Lai, J. M. Ordovas, W. S. Post, S. S. Rich, et al. 2013. Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity. Hum. Genet. 132: 405-13. [online] http://www.ncbi.nlm.nih. gov/pubmed/23263444 (Accessed April 9, 2013).
12. Kabagambe, E. K., J. M. Ordovas, M. Y. Tsai, I. B. Borecki, P. N. Hopkins, S. P. Glasser, and D. K. Arnett. 2009. Smoking, infl ammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis. 203: 633-639. [online] PM:18804210.
13. Tsai, M. Y., A. Georgopoulos, J. D. Otvos, J. M. Ordovas, N. Q. Hanson, J. M. Peacock, and D. K. Arnett. 2004. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantifi cation of triglyceride-rich lipoproteins after an oral fat load. Clin Chem. 50: 1201-1204. [online] PM:15142979.
14. Otvos, J. D., E. J. Jeyarajah, D. W. Bennett, and R. M. Krauss. 1992. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38: 1632-1638.
15. Absher, D. M., X. Li, L. L. Waite, A. Gibson, K. Roberts, J. Edberg, W. W. Chatham, and R. P. Kimberly. 2013. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 9: e1003678. doi:10. 1371/journal. pgen. 1003678.
16. Johnson, W. E., C. Li, and A. Rabinovic. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 8: 118-27. [online] http://www.ncbi.nlm.nih.gov/pubmed/16632515 (Accessed May 21, 2013).
17. Korn, J. M., F. G. Kuruvilla, S. A. McCarroll, A. Wysoker, J. Nemesh, S. Cawley, E. Hubbell, J. Veitch, P. J. Collins, K. Darvishi, et al. 2008. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40: 1253-60. [online] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2756534&tool= pmcentrez&rendertype=abstract (Accessed July 6, 2011).
18. Inc, S. I. 1999. SAS/STAT ® User's Guide, Version 8. SAS Institute Inc, Cary: NC.
19. Atkinson, B., and T. Thereau. 2007. kinship: mixed-effects Cox models, sparse matrices, and modeling data from large pedigrees. R Packag. version. 1.
20. Lamarche, B., I. Lemieux, and J. P. Despres. 1999. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 25: 199-211. [online] PM:10499189.
21. Barakat, H. A., J. W. Carpenter, V. D. McLendon, P. Khazanie, N. Leggett, J. Heath, and R. Marks. 1990. Infl uence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes. 39: 1527-1533. [online] PM:2245877.
22. Frazier-Wood, A. C., E. K. Kabagambe, I. B. Borecki, H. K. Tiwari, J. M. Ordovas, and D. K. Arnett. 2012. Preliminary evidence for an association between LRP-1 genotype and body mass index in humans. PLoS One. 7: e30732. [online] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3275600&tool= pmcentrez&rendertype=abstract (Accessed May 2, 2012).
23. Tang, Z., C. Sun, A. Yan, S. Wu, C. Qin, Y. Zhang, and W. Li. 2013. Genes involved in fatty acid metabolism: Molecular characterization and hypothalamic mRNA response to energy status and neuropeptide Y treatment in the orange-spotted grouper Epinephelus coioides. Mol. Cell. Endocrinol. 376: 114-124. [online] http://www.ncbi.nlm.nih.gov/pubmed/23806557 (Accessed July 18, 2013).
24. Goedeke, L., F. M. Vales-Lara, M. Fenstermaker, D. Cirera-Salinas, A. Chamorro-Jorganes, C. M. Ramírez, J. A. Mattison, R. de Cabo, Y. Suárez, and C. Fernández-Hernando. 2013. A Regulatory Role for MicroRNA 33& in Controlling Lipid Metabolism Gene Expression. Mol. Cell. Biol. 33: 2339-52. [online] http://www.ncbi.nlm.nih.gov/pubmed/23547260 (Accessed May 28, 2013).
25. Yang, Z-H., H. Miyahara, Y. Iwasaki, J. Takeo, and M. Katayama. 2013. Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay mice. Nutr. Metab. (Lond). 10: 16. [online] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3570324&tool=pmcentrez&rendertype=abstract (Accessed July 18, 2013).
26. Fåk, F., and F. Bäckhed. 2012. Lactobacillus reuteri prevents dietinduced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/-mice. PLoS One. 7: e46837. [online] http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3467285&tool=pmcentrez&rendertype=abstract (Accessed June 21, 2013).
27. De Filippis, B., A. Giancristofaro, A. Ammazzalorso, A. D'Angelo, M. Fantacuzzi, L. Giampietro, C. Maccallini, M. Petruzzelli, and R. Amoroso. 2011. Discovery of gemfi brozil analogues that activate PPAR-and enhance the expression of gene CPT1A involved in fatty acids catabolism. Eur. J. Med. Chem. 46: 5218-24. [online] http://dx. doi.org/(Accessed July 6, 2013).
28. Bionaz, M., B. J. Thering, and J. J. Loor. 2012. Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-activation. Br. J. Nutr. 107: 179-91. [online] http://www.ncbi.nlm.nih.gov/pubmed/21729373 (Accessed June 11, 2013).
29. Lemas, D. J., H. W. Wiener, D. M. O'Brien, S. Hopkins, K. L. Stanhope, P. J. Havel, D. B. Allison, J. R. Fernandez, H. K. Tiwari, and B. B. Boyer. 2012. Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos. J. Lipid Res. 53: 175-84. [online] http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3243474&tool=pmcentrez&rendertype=abstract (Accessed July 18, 2013).
30. Teslovich, T. M., K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou, M. Koseki, J. P. Pirruccello, S. Ripatti, D. I. Chasman, C. J. Willer, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466: 707-713.
31. Gillingham, M. B., M. Hirschfeld, S. Lowe, D. Matern, J. Shoemaker, W. E. Lambert, and D. M. Koeller. 2011. Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant. Mol. Genet. Metab. 104: 261-4. [online] http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid= 3197793&tool=pmcentrez&rendertype=abstract (Accessed July 18, 2013).
32. Gemma, C., S. Sookoian, G. Dieuzeide, S. I. Garcia, T. F. Gianotti, C. D. Gonzalez, and C. J. Pirola. 2010. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab. 100: 83-87. [online] PM:20202876.
33. Maier, S., and A. Olek. 2002. Diabetes: a candidate disease for effi cient DNA methylation profi ling. J Nutr. 132: 2440S-2443S. [online] PM:12163708.
34. Kirk, H., W. T. Cefalu, D. Ribnicky, Z. Liu, and K. J. Eilertsen. 2008. Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome. Metabolism. 57: S16-S23. [online] PM:18555849.
35. Jeyarajah, E. J., W. C. Cromwell, and J. D. Otvos. 2006. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin. Lab. Med. 26: 847-870.